BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 28602505)

  • 1. Proposal of 5-methoxy-N-methyl-N-isopropyltryptamine consumption biomarkers through identification of in vivo metabolites from mice.
    Fabregat-Safont D; Barneo-Muñoz M; Martinez-Garcia F; Sancho JV; Hernández F; Ibáñez M
    J Chromatogr A; 2017 Jul; 1508():95-105. PubMed ID: 28602505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of the in vitro and in vivo metabolism of the tryptamine 5-MeO-MiPT using human liver microsomes and real case samples.
    Grafinger KE; Hädener M; König S; Weinmann W
    Drug Test Anal; 2018 Mar; 10(3):562-574. PubMed ID: 28677880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of the tryptamine-derived new psychoactive substances 5-MeO-2-Me-DALT, 5-MeO-2-Me-ALCHT, and 5-MeO-2-Me-DIPT and their detectability in urine studied by GC-MS, LC-MS
    Caspar AT; Gaab JB; Michely JA; Brandt SD; Meyer MR; Maurer HH
    Drug Test Anal; 2018 Jan; 10(1):184-195. PubMed ID: 28342193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A general screening and confirmation approach to the analysis of designer tryptamines and phenethylamines in blood and urine using GC-EI-MS and HPLC-electrospray-MS.
    Vorce SP; Sklerov JH
    J Anal Toxicol; 2004 Sep; 28(6):407-10. PubMed ID: 15516287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmaco-toxicological effects of the novel tryptamine hallucinogen 5-MeO-MiPT on motor, sensorimotor, physiological, and cardiorespiratory parameters in mice-from a human poisoning case to the preclinical evidence.
    Bassi M; Bilel S; Tirri M; Corli G; Di Rosa F; Gregori A; Alkilany AM; Rachid O; Roda E; Zauli G; Locatelli CA; Marti M
    Psychopharmacology (Berl); 2024 Mar; 241(3):489-511. PubMed ID: 38214743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of the psychotomimetic tryptamine derivative 5-methoxy-N,N-diisopropyltryptamine in humans: identification and quantification of its urinary metabolites.
    Kamata T; Katagi M; Kamata HT; Miki A; Shima N; Zaitsu K; Nishikawa M; Tanaka E; Honda K; Tsuchihashi H
    Drug Metab Dispos; 2006 Feb; 34(2):281-7. PubMed ID: 16280455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of the new psychoactive substances N,N-diallyltryptamine (DALT) and 5-methoxy-DALT and their detectability in urine by GC-MS, LC-MSn, and LC-HR-MS-MS.
    Michely JA; Helfer AG; Brandt SD; Meyer MR; Maurer HH
    Anal Bioanal Chem; 2015 Oct; 407(25):7831-42. PubMed ID: 26297461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of 5-MeO-DIPT in Human Urine Using Gas Chromatography Coupled with High-Resolution Orbitrap Mass Spectrometry.
    Yan X; Xiang P; Zhao Y; Yu Z; Yan H
    J Anal Toxicol; 2020 Apr; 44(5):461-469. PubMed ID: 32020169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A quantitative method for simultaneous determination of 5-methoxy-N,N-diisopropyltryptamine and its metabolites in urine using liquid chromatography-electrospray ionization-tandem mass spectrometry.
    Jin MJ; Jin C; Kim JY; In MK; Kwon OS; Yoo HH
    J Forensic Sci; 2011 Jul; 56(4):1044-8. PubMed ID: 21418218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and analytical characterization of nine synthetic cathinone derivatives N-ethylhexedrone, 4-Cl-pentedrone, 4-Cl-α-EAPP, propylone, N-ethylnorpentylone, 6-MeO-bk-MDMA, α-PiHP, 4-Cl-α-PHP, and 4-F-α-PHP.
    Liu C; Jia W; Li T; Hua Z; Qian Z
    Drug Test Anal; 2017 Aug; 9(8):1162-1171. PubMed ID: 27863142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Foxy, a designer tryptamine hallucinogen.
    Meatherall R; Sharma P
    J Anal Toxicol; 2003; 27(5):313-7. PubMed ID: 12908946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A fatal poisoning with 5-methoxy-N,N-diisopropyltryptamine, Foxy.
    Tanaka E; Kamata T; Katagi M; Tsuchihashi H; Honda K
    Forensic Sci Int; 2006 Nov; 163(1-2):152-4. PubMed ID: 16406422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A foxy intoxication.
    Wilson JM; McGeorge F; Smolinske S; Meatherall R
    Forensic Sci Int; 2005 Feb; 148(1):31-6. PubMed ID: 15607587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analytical chemistry of synthetic routes to psychoactive tryptamines. Part I. Characterisation of the Speeter and Anthony synthetic route to 5-methoxy-N,N-diisopropyltryptamine using ESI-MS-MS and ESI-TOF-MS.
    Brandt SD; Freeman S; Fleet IA; McGagh P; Alder JF
    Analyst; 2004 Nov; 129(11):1047-57. PubMed ID: 15508033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigating the ability of the microbial model Cunninghamella elegans for the metabolism of synthetic tryptamines.
    Grafinger KE; Wilke A; König S; Weinmann W
    Drug Test Anal; 2019 May; 11(5):721-729. PubMed ID: 30462883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biotransformation and detectability of the new psychoactive substances N,N-diallyltryptamine (DALT) derivatives 5-fluoro-DALT, 7-methyl-DALT, and 5,6-methylenedioxy-DALT in urine using GC-MS, LC-MS
    Michely JA; Brandt SD; Meyer MR; Maurer HH
    Anal Bioanal Chem; 2017 Feb; 409(6):1681-1695. PubMed ID: 27933361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nontargeted metabolomic insights into the behavioral effects of 5-MeO-MiPT in zebrafish (Danio rerio).
    Zhao S; Chen J; Zhong C; Meng L; Wang Y
    Ecotoxicol Environ Saf; 2024 Mar; 272():116044. PubMed ID: 38295732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A high-sensitivity ultra-high performance liquid chromatography/high-resolution time-of-flight mass spectrometry (UHPLC-HR-TOFMS) method for screening synthetic cannabinoids and other drugs of abuse in urine.
    Sundström M; Pelander A; Angerer V; Hutter M; Kneisel S; Ojanperä I
    Anal Bioanal Chem; 2013 Oct; 405(26):8463-74. PubMed ID: 23954996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of hair analysis to document illegal 5-methoxy-N,N-dissopropyltrptamine (5-MeO-DiPT) use.
    Wang R; Xiang P; Yu Z; Shi Y
    Forensic Sci Int; 2019 Nov; 304():109972. PubMed ID: 31604205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of new psychoactive substances in oral fluids by means of microextraction by packed sorbent followed by ultra-high-performance liquid chromatography-tandem mass spectrometry.
    Rocchi R; Simeoni MC; Montesano C; Vannutelli G; Curini R; Sergi M; Compagnone D
    Drug Test Anal; 2018 May; 10(5):865-873. PubMed ID: 29078252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.